A download link will be emailed after check out.
Lonsurf is indicated for the treatment of adult patients with metastatic bowel cancer (mCRC) who have been previously treated with, or are not considered candidates for fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents
